NIH Policies and Regulatory Pathways for the Advancement of Radiation Medical Countermeasures and Biodosimetry Tools to U.S. FDA Licensure
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
An Overview of Radiation Countermeasure Development in Radiation Research from 1954 to 2024.
Kiang J, Cannon G, Singh V Radiat Res. 2024; 202(2):420-431.
PMID: 38964743 PMC: 11385179. DOI: 10.1667/RADE-24-00036.1.
References
1.
Farese A, Cohen M, Katz B, Smith C, Gibbs A, Cohen D
. Filgrastim improves survival in lethally irradiated nonhuman primates. Radiat Res. 2012; 179(1):89-100.
PMC: 4562422.
DOI: 10.1667/RR3049.1.
View
2.
Royba E, Repin M, Balajee A, Shuryak I, Pampou S, Karan C
. The RABiT-II DCA in the Rhesus Macaque Model. Radiat Res. 2020; 196(5):501-509.
PMC: 9039759.
DOI: 10.1667/RR15547.1.
View
3.
Rios C, Cassatt D, DiCarlo A, Macchiarini F, Ramakrishnan N, Norman M
. Building the strategic national stockpile through the NIAID Radiation Nuclear Countermeasures Program. Drug Dev Res. 2014; 75(1):23-8.
PMC: 8365557.
DOI: 10.1002/ddr.21163.
View
4.
Parker G, Li N, Takayama K, Farese A, MacVittie T
. Lung and Heart Injury in a Nonhuman Primate Model of Partial-body Irradiation with Minimal Bone Marrow Sparing: Histopathological Evidence of Lung and Heart Injury. Health Phys. 2019; 116(3):383-400.
PMC: 6381599.
DOI: 10.1097/HP.0000000000000936.
View
5.
Moulder J, Fish B
. Late toxicity of total body irradiation with bone marrow transplantation in a rat model. Int J Radiat Oncol Biol Phys. 1989; 16(6):1501-9.
DOI: 10.1016/0360-3016(89)90955-3.
View